218 related articles for article (PubMed ID: 1898604)
1. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa.
Markham RB; Pier GB; Schreiber JR
J Immunol; 1991 Jan; 146(1):316-20. PubMed ID: 1898604
[TBL] [Abstract][Full Text] [Related]
2. Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody response.
Markham RB; Powderly WG
J Immunol; 1988 Mar; 140(6):2039-45. PubMed ID: 3126239
[TBL] [Abstract][Full Text] [Related]
3. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.
Pier GB; Markham RB
J Immunol; 1982 May; 128(5):2121-5. PubMed ID: 6174622
[TBL] [Abstract][Full Text] [Related]
4. T cells recognizing polysaccharide-specific B cells function as contrasuppressor cells in the generation of T cell immunity to Pseudomonas aeruginosa.
Powderly WG; Schreiber JR; Pier GB; Markham RB
J Immunol; 1988 Apr; 140(8):2746-52. PubMed ID: 3128607
[TBL] [Abstract][Full Text] [Related]
5. In vitro T cell-mediated killing of Pseudomonas aeruginosa. I. Evidence that a lymphokine mediates killing.
Markham RB; Goellner J; Pier GB
J Immunol; 1984 Aug; 133(2):962-8. PubMed ID: 6429246
[TBL] [Abstract][Full Text] [Related]
6. In vitro T cell-mediated killing of Pseudomonas aeruginosa. IV. Nonresponsiveness in polysaccharide-immunized BALB/c mice is attributable to vinblastine-sensitive suppressor T cells.
Powderly WG; Pier GB; Markham RB
J Immunol; 1986 Sep; 137(6):2025-30. PubMed ID: 2943808
[TBL] [Abstract][Full Text] [Related]
7. In vitro T cell-mediated killing of Pseudomonas aeruginosa. V. Generation of bactericidal T cells in nonresponder mice.
Powderly WG; Pier GB; Markham RB
J Immunol; 1987 Apr; 138(7):2272-7. PubMed ID: 2951437
[TBL] [Abstract][Full Text] [Related]
8. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
10. Suppressor T cells regulating the cell-mediated immune response to Pseudomonas aeruginosa can be generated by immunization with anti-bacterial T cells.
Markham RB; Pier GB; Powderly WG
J Immunol; 1988 Dec; 141(11):3975-9. PubMed ID: 2460554
[TBL] [Abstract][Full Text] [Related]
11. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
[TBL] [Abstract][Full Text] [Related]
12. T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.
Powderly WG; Pier GB; Markham RB
J Clin Invest; 1986 Aug; 78(2):375-80. PubMed ID: 2426306
[TBL] [Abstract][Full Text] [Related]
13. In vitro T cell-mediated killing of Pseudomonas aeruginosa. III. The role of suppressor T cells in nonresponder mice.
Powderly WG; Pier GB; Markham RB
J Immunol; 1986 Jan; 136(1):299-303. PubMed ID: 2933465
[TBL] [Abstract][Full Text] [Related]
14. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
[TBL] [Abstract][Full Text] [Related]
15. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
[TBL] [Abstract][Full Text] [Related]
17. Role of specific delayed-type hypersensitivity in Pseudomonas aeruginosa-infected mice.
Colizzi V; Garzelli C; Campa M; Toca L; Falcone G
Immunology; 1982 Oct; 47(2):337-44. PubMed ID: 6811422
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.
Lang AB; Fürer E; Schürch U; Cross AS; Larrick JW; Cryz SJ
Dev Biol Stand; 1990; 71():121-6. PubMed ID: 1698165
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response.
Abraham E; Shah S
J Immunol; 1992 Dec; 149(11):3719-26. PubMed ID: 1431143
[TBL] [Abstract][Full Text] [Related]
20. In vitro T cell-mediated killing of Pseudomonas aeruginosa. II. The role of macrophages and T cell subsets in T cell killing.
Markham RB; Pier GB; Goellner JJ; Mizel SB
J Immunol; 1985 Jun; 134(6):4112-7. PubMed ID: 3921618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
